Featured Firms
Presented by BigVoodoo
Having failed to prevent FDA approval of the abortion drug Mifepristone, also known as RU-486, abortion foes are lobbying for tougher restrictions on doctors who could prescribe it. But the proposed legislation, requiring doctors be qualified to perform surgical abortions on patients taking RU-486, would defeat the pro-choice goal of expanding abortion availability beyond the clinic setting.
October 11, 2000 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS